Conexeu Sciences (CNXU)

Currency in USD
9.65
+0.77(+8.67%)
Closed·
9.70+0.05(+0.52%)
·
CNXU is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.5710.19
52 wk Range
8.1418.79
Key Statistics
Prev. Close
9.65
Open
8.8
Day's Range
8.57-10.19
52 wk Range
8.14-18.79
Volume
116.2K
Average Volume (3m)
103.37K
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNXU Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.00
Upside
+107.25%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

Conexeu Sciences News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 20.00
(+107.25% Upside)

Earnings

Latest Release
01/07/2026
EPS / Forecast
-0.11 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare CNXU to Peers and Sector

Metrics to compare
CNXU
Peers
Sector
Relationship
P/E Ratio
−35.9x−6.3x−0.4x
PEG Ratio
-0.050.00
Price/Book
35.9x1.4x2.6x
Price / LTM Sales
-15.6x3.0x
Upside (Analyst Target)
107.3%308.2%54.8%
Fair Value Upside
Unlock2.5%9.0%Unlock

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company’s solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

People Also Watch

2.51
VIDA
+10.57%
10.09
APURU
+0.50%
1.11
MWC
-34.32%
12.99
GMRS
+0.23%
3.08
EXYN
-7.51%

FAQ

What Is the Conexeu Sciences (NASDAQ: CNXU) Share Price Today?

The Conexeu Sciences stock price today is 9.65 USD.

What Stock Exchange Does Conexeu Sciences (CNXU) Trade On?

Conexeu Sciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Conexeu Sciences?

The stock symbol (also called a 'ticker') for Conexeu Sciences is "CNXU."

What Is the Current Conexeu Sciences Market Capitalisation?

As of today, Conexeu Sciences (NASDAQ: CNXU) market cap is 258.22M USD.

What Is Conexeu Sciences's (CNXU) Earnings Per Share (TTM)?

The Conexeu Sciences EPS is currently -0.39 (Trailing Twelve Months).

When Is the Next Conexeu Sciences Earnings Date?

Conexeu Sciences's next earnings report will be released on 30/09/2026.

Is CNXU a Buy or Sell From a Technical Analyst Perspective?

Based on today's Conexeu Sciences moving averages and other technical indicators, the daily buy/sell signal for CNXU stock is Strong Sell.

How Many Times Has Conexeu Sciences Stock Split?

Conexeu Sciences has split 0 times. (See the CNXU stock split history page for full effective split date and price information.)

What is the current trading status of Conexeu Sciences (NASDAQ: CNXU)?

As of 22/07/2026, Conexeu Sciences (CNXU) is trading at a share price of 9.65 USD, with a previous close of 9.65 USD. The stock has fluctuated within a day range of 8.57 USD to 10.19 USD, while its 52-week range spans from 8.14 USD to 18.79 USD.

What Is Conexeu Sciences (CNXU) Price Target According to Analysts?

The average 12-month price target for Conexeu Sciences is 20.00 USD, with a high estimate of 20 USD and a low estimate of 20 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +107.25% Upside potential.

What Is the CNXU Premarket Price?

CNXU's last pre-market stock price is 9.70 USD. The pre-market share volume is 150.00, and the stock has decreased by 0.05, or 0.52%.

What Is the CNXU After Hours Price?

CNXU's last after hours stock price is 9.39 USD, the stock has decreased by -0.26, or -2.69%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.